Clorox (NYSE:CLX) Price Target Raised to $86.00

Clorox (NYSE:CLX) had its price target raised by Barclays from $85.00 to $86.00 in a research note released on Tuesday,Benzinga reports. They currently have an underweight rating on the stock.

Several other research firms have also commented on CLX. UBS Group raised their price target on shares of Clorox from $96.00 to $100.00 and gave the company a “neutral” rating in a report on Thursday, July 16th. Evercore reaffirmed an “underperform” rating and issued a $110.00 target price on shares of Clorox in a research report on Friday, May 1st. TD Cowen raised their price target on shares of Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a report on Tuesday, March 31st. Citigroup lowered their price objective on Clorox from $110.00 to $97.00 and set a “neutral” rating for the company in a research note on Friday, May 1st. Finally, Royal Bank Of Canada decreased their price objective on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a report on Thursday, April 9th. One equities research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have given a Sell rating to the stock. Based on data from MarketBeat, Clorox currently has an average rating of “Reduce” and a consensus price target of $102.80.

Clorox Price Performance

CLX opened at $93.81 on Tuesday. Clorox has a 1 year low of $84.70 and a 1 year high of $132.00. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The company’s 50 day simple moving average is $95.00 and its 200 day simple moving average is $103.89. The stock has a market capitalization of $11.34 billion, a PE ratio of 15.23 and a beta of 0.54.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same quarter last year, the business earned $1.45 EPS. Clorox’s revenue for the quarter was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, sell-side analysts expect that Clorox will post 5.52 EPS for the current year.

Insider Buying and Selling at Clorox

In other news, Director Pierre R. Breber acquired 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 5th. The shares were purchased at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the transaction, the director directly owned 18,000 shares in the company, valued at $1,544,760. This trade represents a 38.46% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.63% of the stock is currently owned by company insiders.

Institutional Trading of Clorox

Several hedge funds have recently added to or reduced their stakes in CLX. Caitlin John LLC grew its stake in shares of Clorox by 1,807.1% in the fourth quarter. Caitlin John LLC now owns 267 shares of the company’s stock worth $27,000 after purchasing an additional 253 shares in the last quarter. Darwin Wealth Management LLC bought a new stake in shares of Clorox in the 2nd quarter worth $29,000. Vision Financial Markets LLC raised its position in Clorox by 166.7% in the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after acquiring an additional 200 shares in the last quarter. Root Financial Partners LLC raised its holdings in shares of Clorox by 83.8% in the 1st quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock worth $33,000 after purchasing an additional 145 shares in the last quarter. Finally, SHP Wealth Management acquired a new stake in shares of Clorox during the 4th quarter valued at $35,000. Institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.